The role of selective imidazoline receptor agonists in modern hypertension management: an international real-world survey (STRAIGHT)

Author:

Schlaich Markus P.123ORCID,Almahmeed Wael4,Arnaout Samir5,Prabhakaran Dorairaj67,Zhernakova Julia8,Zvartau Nadezhda9,Schutte Aletta E.1011ORCID

Affiliation:

1. Dobney Hypertension Centre, School of Medicine – Royal Perth Hospital Unit/Medical Research Foundation, University of Western Australia, Perth, Australia

2. Departments of Cardiology and Nephrology, Royal Perth Hospital, Perth, Australia

3. Neurovascular Hypertension and Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia

4. Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

5. Division of Cardiology, Department of Internal Medicine, American University of Beirut-Medical Center, Lebanon

6. Chronic Disease, Centre for Control of Chronic Conditions (CCCC), New Delhi, India

7. Epidemiology, Public Health Foundation of India (PHFI), New Delhi, India

8. National Medical Research Center of Cardiology, Moscow, Russia

9. Almazov National Medical Research Centre, Saint-Petersburg, Russia

10. Hypertension in Africa Research Team, MRC Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa

11. School of Population Health, The George Institute for Global Health, University of New South Wales, Sydney, Australia

Publisher

Informa UK Limited

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3